Abacus Global Management (ABX) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
1 Feb, 2026Executive summary
Q2 2024 revenue more than doubled year-over-year to $29.1 million, driven by strong active management and origination growth.
Adjusted EBITDA rose 83% to $16.7 million, with a margin of 57.5%.
Adjusted net income increased 75% to $11.8 million, or $0.18 per diluted share.
Net income attributable to stockholders was $0.8 million, down from $6.8 million in Q2 2023, reflecting higher expenses.
Announced acquisitions of Carlisle Management and FCF Advisors, adding $2.6 billion in AUM and expanding asset management capabilities.
Financial highlights
Q2 2024 revenue was $29.1 million, up 155.6% from $11.4 million in Q2 2023.
Gross profit for Q2 2024 was $26.3 million, up 153.1% year-over-year.
Origination capital deployed reached $104.7 million, up from $59.8 million year-over-year; policies purchased increased 95% to 275.
Adjusted EBITDA margin was 57.5%, down from 80.4% in Q2 2023.
Cash and cash equivalents as of June 30, 2024, were $91.3 million.
Outlook and guidance
Management expects continued strong performance and profitability, supported by recent acquisitions and favorable market conditions.
Majority of the $90 million capital raised in June is expected to be deployed before year-end.
Sufficient liquidity and cash flow are anticipated to support operations and debt service for the next 12 months.
Acquisitions are expected to accelerate international expansion and broaden product offerings.
Latest events from Abacus Global Management
- FY26 guidance raised as Q1 revenue, cash flow, and AUM surge on strong capital inflows.ABX
Q1 202611 May 2026 - Longevity, AI, and private markets are transforming wealth management and investment priorities.ABX
29th Annual Global Conference9 May 2026 - Outstanding shares corrected to 96,138,555; no impact on proposals or board recommendations.ABX
Proxy filing29 Apr 2026 - Shareholders will vote on director elections, auditor ratification, and a new equity plan.ABX
Proxy filing21 Apr 2026 - Investing in longevity market assets provides uncorrelated, investment-grade returns in a regulated space.ABX
Corporate presentation30 Mar 2026 - Record 2025 revenue and earnings growth, with robust 2026 outlook and new capital returns.ABX
Q4 202512 Mar 2026 - Record 2024 growth and acquisitions set stage for 51–68% adjusted net income rise in 2025.ABX
Q4 202412 Mar 2026 - Expanding via acquisitions and data services, driving growth in the uncorrelated life settlements market.ABX
17th Annual LD Micro Main Event Conference3 Feb 2026 - Q3 revenue up 33% and adjusted EBITDA up 54%, with $2.6B in AUM from acquisitions pending.ABX
Q3 202415 Jan 2026